C12Y 107/01001
Nitrate reductase
Official title: Nitrate reductase (NADH) (1.7.1.1)
C12Y107/01001 (Nitrate reductase) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 8
- Assignees
- 8
- Inventors
- 33
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reducing nitrate reductase activity in tabacco and methods for its use29 Sep 2026US 12,745,741 B2Japan Tobacco Inc.
- Modulation of nitrate levels in plants via mutation of nitrate reductase7 May 2024US 11,976,286 B2Philip Morris Products S. A.
- Reducing tobacco specific nitrosamines through alteration of the nitrate assimilation pathway6 Jun 2023US 11,666,082 B2North Carolina State University
- Inducible expression of genes in algae2 Nov 2021US 11,162,106 B2Synthetic Genomics, Inc.
- Nitrate reductase fusion proteins and uses thereof2 Apr 2013US 8,409,827 B2University of Delaware
- Recombinant yeast cell30 Oct 2025US 2025/0333768 A1Danisco US Inc.
- Ricinoleate Oil Production and Uses Thereof7 Aug 2025US 2025/0248921 A1Checkerspot, Inc.
- Tobacco plant and tobacco product12 Oct 2023US 2023/0320309 A1Japan Tobacco Inc.
- Modulation of nitrate levels in plants via mutation of nitrate reductase16 Jun 2022US 2022/0186242 A1Philip Morris Products S. A.
- Inducible expression of genes in algae27 Jan 2022US 2022/0025390 A1Synthetic Genomics, Inc.
Most cited
By later US patents